Apart from tumor-related diseases, “Obesity” and “Atherosclerosis” also appeared frequently in our results, suggesting that METTL3 may influence multiple pathways in other diseases. Here, METTL3 is linked to obesity due to melanocortin 4 receptor deficiency.